Delivery Order SPE2DB22D3501-SPE2DB25FVU50

Award Date 5/23/25
Potential Completion Date 5/27/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,457.99 firm fixed-price delivery order is for the supply of TRINTELLIX 10 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance through May 9, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $1,746.21 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 4564604011 TRINTELLIX 10 MG TABLET 30S, a prescription pharmaceutical product, with a performance period ending on May 15, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,562.76 firm fixed-price delivery order is for the supply of TRINTELLIX 10 MG TABLET 30S, a medication, with a period of performance through August 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order (SPE2DB22D1202|SPE2DB24FUWV1) worth $1,510.80 for the supply of TRINTELLIX 10 MG TABLETs. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TRINTELLIX 5 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,821.85 and is a Firm Fixed Price Delivery Order that runs through October 23, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $2,309.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of TRINTELLIX 10 MG TABLET 30S, a pharmaceutical product, with a performance period ending on May 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and...
This federal contract award, valued at $1,931.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of TRINTELLIX 10 MG TABLET 30S, a prescription medication. The contract is a firm fixed price arrangement with a completion date of July 14, 2022. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,145.70 firm fixed-price delivery order is for the medication Trintellix 20 mg tablet, with a period of performance through April 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,001.57 firm fixed-price delivery order is for the supply of TRINTELLIX 10 MG TABLET 30S, a medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,803.14 firm fixed-price delivery order is for the supply of TRINTELLIX 10 MG TABLET 30S, a medication used in the treatment of major depressive disorder. The award has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVU50
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $8,107.27 firm fixed-price delivery order is for the supply of TRINTELLIX 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 27, 2025.

Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard. The contract award does not have a set-aside designation, indicating open competition.

Generated 8/22/25, 10:01 AM